Elizabeth O'Donnell, MD

Assistant Professor of Medicine
Dana-Farber Cancer Institute

Poster(s):

• P-504: A Phase II Study of Isatuximab, Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, and in Newly Diagnosed, Transplant-Eligible Multiple Myeloma (The SKylaRk Trial)
  Thursday, September 28, 2023

  12:30 PM – 1:30 PM EEST